PD-1 and CTLA-4 Modulation via Lifestyle and Supplements: What Biology Supports — and What It Does Not (2026)
Abstract Immune checkpoint pathways such as programmed cell death-1 (PD-1) and cytotoxic T-lymphocyte–associated protein 4 (CTLA-4) play a central role in regulating immune activation, tolerance, and exhaustion. While pharmaceutical checkpoint inhibitors have transformed cancer treatment, there is growing interest in whether lifestyle factors and dietary supplements can modulate these pathways indirectly. This article reviews the biological plausibility, preclinical evidence, and limitations surrounding non-pharmacologic modulation of PD-1 and CTLA-4 signaling, emphasizing immune tone optimization rather than immune checkpoint blockade. Keywords: PD-1, CTLA-4, immune checkpoints, immune exhaustion, lifestyle medicine, supplements, immunometabolism Scope and Intent This article is educational and mechanistic , not therapeutic guidance. It does not suggest lifestyle or supplements can replace immune checkpoint inhibitors. It does not advocate off-label cancer treatment. It examines in...